Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VI-TWEL | Bayer | N-007012 DISCN | 1982-01-01 | 1 products |
RUBIVITE | Bel-Mar Laboratories | N-010791 DISCN | 1982-01-01 | 5 products |
RUBRAMIN PC | Bristol Myers Squibb | N-006799 DISCN | 1982-01-01 | 3 products, RLD |
CALOMIST | Endo | N-022102 DISCN | 2007-07-27 | 1 products |
NASCOBAL | Endo | N-019722 DISCN | 1996-11-05 | 1 products |
NASCOBAL | Endo | N-021642 DISCN | 2005-01-31 | 1 products, RLD |
REDISOL | Merck & Co | N-006668 DISCN | 1982-01-01 | 1 products |
BERUBIGEN | Pharmacia & Upjohn | N-006798 DISCN | 1982-01-01 | 1 products |
CYANOCOBALAMIN | Warner Chilcott | N-007085 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DICOPAC KIT | GE Healthcare | N-017406 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DEPINAR | Armour Pharmaceutical | N-011208 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
adult infuvite multiple vitamins | New Drug Application | 2019-05-14 |
adult infuvite multiple vitamins for infusion pharmacy bulk | New Drug Application | 2013-01-01 |
animi-3 | unapproved drug other | 2013-02-06 |
animi-3 with vitamin d | unapproved drug other | 2011-05-23 |
bacmin | unapproved drug other | 2014-05-02 |
bal-care dha | unapproved drug other | 2012-05-01 |
bal-care dha essential | unapproved drug other | 2012-05-01 |
bp vit 3 | unapproved drug other | 2023-10-11 |
c-nate dha | unapproved drug other | 2024-01-22 |
centratex | unapproved drug other | 2024-01-31 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 8 | 35 | 23 | 2 | 1 | 63 |
Vitamin b 12 deficiency | D014806 | EFO_0000734 | E53.8 | 2 | 4 | 2 | 4 | 45 | 55 |
Anemia | D000740 | HP_0001903 | D64.9 | — | 4 | 9 | 7 | 32 | 50 |
Neoplasms | D009369 | — | C80 | 13 | 15 | 6 | 5 | 3 | 37 |
Lymphoma | D008223 | — | C85.9 | 11 | 19 | 7 | 1 | 1 | 35 |
Syndrome | D013577 | — | — | 3 | 4 | 6 | 3 | 18 | 31 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 3 | 3 | 4 | 19 | 27 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 6 | 5 | 1 | 14 | 25 |
Iron deficiencies | D000090463 | — | — | — | 1 | 3 | 4 | 16 | 23 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | 5 | 6 | 3 | 9 | 22 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma | D000230 | — | — | 8 | 12 | 16 | — | 3 | 35 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 13 | 17 | 6 | — | 1 | 30 |
Non-small-cell lung carcinoma | D002289 | — | — | 3 | 14 | 9 | — | 3 | 26 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | — | 15 | 6 | — | 3 | 23 |
Leukemia | D007938 | — | C95 | 5 | 10 | 7 | — | 1 | 22 |
Colonic neoplasms | D003110 | — | C18 | 1 | 5 | 13 | — | — | 18 |
Carcinoma | D002277 | — | C80.0 | 5 | 7 | 6 | — | 1 | 17 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 4 | 10 | 4 | — | 1 | 17 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | — | 2 | 6 | 7 | — | 1 | 15 |
Covid-19 | D000086382 | — | — | 2 | 2 | 3 | — | 8 | 14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | 3 | — | — | 12 | 16 |
Heart failure | D006333 | HP_0001635 | I50 | 2 | 2 | — | — | 3 | 6 |
Mucositis | D052016 | EFO_1001898 | — | 1 | 5 | — | — | — | 6 |
Aging | D000375 | GO_0007568 | R41.81 | 1 | 2 | — | — | 3 | 6 |
Micronutrients | D018977 | — | — | — | 1 | — | — | 5 | 6 |
Recurrence | D012008 | — | — | 1 | 2 | — | — | 2 | 5 |
Prostatic neoplasms | D011471 | — | C61 | 1 | 3 | — | — | 1 | 5 |
Myeloid leukemia | D007951 | — | C92 | 2 | 3 | — | — | — | 5 |
Triple negative breast neoplasms | D064726 | — | — | 2 | 3 | — | — | — | 4 |
Chronic pain | D059350 | HP_0012532 | — | — | 2 | — | — | 2 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Weight loss | D015431 | HP_0001824 | — | 1 | — | — | — | 4 | 5 |
Carpal tunnel syndrome | D002349 | EFO_0004143 | G56.0 | 1 | — | — | — | 4 | 5 |
Metabolic diseases | D008659 | EFO_0000589 | E88.9 | 1 | — | — | — | 3 | 4 |
Preleukemia | D011289 | — | — | 3 | — | — | — | — | 3 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | — | — | — | 2 | 3 |
T-cell lymphoma cutaneous | D016410 | — | — | 2 | — | — | — | — | 2 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | — | — | — | 1 | 2 |
Cognition disorders | D003072 | — | — | 1 | — | — | — | 1 | 2 |
Inflammatory bowel diseases | D015212 | EFO_0003767 | — | 1 | — | — | — | 1 | 2 |
Intestinal diseases | D007410 | HP_0002242 | K63.9 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Folic acid deficiency | D005494 | EFO_0001070 | E53.8 | — | — | — | — | 11 | 11 |
Deglutition disorders | D003680 | HP_0002015 | R13.1 | — | — | — | — | 8 | 8 |
Gyrate atrophy | D015799 | — | — | — | — | — | — | 6 | 6 |
Vitamin a deficiency | D014802 | EFO_1001237 | E50 | — | — | — | — | 6 | 6 |
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | — | — | 6 | 6 |
Body weight | D001835 | EFO_0004338 | — | — | — | — | — | 4 | 4 |
Cerebral palsy | D002547 | — | G80 | — | — | — | — | 4 | 4 |
Cerebral small vessel diseases | D059345 | — | — | — | — | — | — | 4 | 4 |
Progressive bulbar palsy | D010244 | EFO_0003783 | G12.1 | — | — | — | — | 4 | 4 |
Child development | D002657 | — | — | — | — | — | — | 3 | 3 |
Drug common name | Cyanocobalamin |
INN | cyanocobalamin |
Description | Cyanocobalamin is a form of vitamin B12 used to treat vitamin B12 deficiency except in the presence of cyanide toxicity. The deficiency may occur in pernicious anemia, following surgical removal of the stomach, with fish tapeworm, or due to bowel cancer. It is less preferred than hydroxocobalamin for treating vitamin B12 deficiency. Some study have shown that it has an antihypotensive effect. It is used by mouth, by injection into a muscle, or as a nasal spray.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 68-19-9 |
RxCUI | — |
ChEMBL ID | CHEMBL2110563 |
ChEBI ID | — |
PubChem CID | 16212801 |
DrugBank | DB00115 |
UNII ID | P6YC3EG204 (ChemIDplus, GSRS) |